VPTDF - Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services
(TheNewswire)
Toronto, Ontario – TheNewswire –January 27, 2022 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ; ( OTC:VPTDF) announces it has enteredinto an investor relations agreement (the “IR Agreement”) withIconic Investor Relations LLC (“Iconic”). The IR Agreement isfor a term of twelve months commencing on January 20, 2022.
“ With our recent uplisting tothe OTCQB, we are looking forward to working with Iconic to informshareholders and new investors in the United States about theCompany’s progress to improve cardiac care worldwide,” stated Dr. George Adams, Executive-Chairman ofVentripoint.
John Grosso, President Iconic, stated: "Wespecialize in outreach to investors who are interested in companieswith novel medical products, which will change healthcare in theUnited States and Ventripoint meets all our criteria with itsdisruptive technology to better visualize the heart using routineultrasound exams.”
Pursuant to the IR Agreement, Iconic will be paid a feeof USD$10,000 per month and will be granted stock options to purchase250,000 common shares of Ventripoint at a price of $0.33 per share fora term of two years vesting quarterly over 1 year, in accordance withthe Ventripoint’s stock option plan.
The IR Agreement and grant of the options are subjectto the approval of the TSX Venture Exchange.
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada.
For further information, pleasecontact:
Peter Weichler, Investor Relations
Email: peter@weichler.ca
or
John Grosso, Iconic InvestorRelations
Email: john@iconiconsulting.com
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Company.Although the Company believes that the expectations and assumptions onwhich such forward-looking statements and information are based arereasonable, undue reliance should not be placed on the forward-lookingstatements and information because the Company can give no assurancethat they will prove to be correct.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.
Copyright (c) 2022 TheNewswire - All rights reserved.